Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

3.45
Delayed Data
As of Sep 23
 +0.03 / +0.88%
Today’s Change
2.44
Today|||52-Week Range
10.60
-60.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues1.9M10.9M489.0K483.0K
 
 
 
 
 
Depreciation And Amortization379.0K414.0K419.0K509.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses14.8M17.8M21.4M21.2M
 
 
 
 
 
Research And Development11.0M12.8M16.8M18.0M
 
 
 
 
 
Total Operating Expenses15.2M18.2M21.9M21.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.3M-7.4M-21.4M-21.2M
 
 
 
 
 
Interest Expense On Debt6.0K30.0K24.0K90.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.0M-7.2M-21.2M-21.1M
 
 
 
 
 
Income Taxes-16.0K-4.0K-5.0K-8.0K
 
 
 
 
 
Net Income-13.0M-7.2M-21.2M-21.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.0M52.5M52.7M52.8M
 
 
 
 
 
Shares To Calculate EPS Diluted52.0M52.5M52.7M52.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.14-$0.40-$0.40
 
 
 
 
 
EPS Diluted-$0.25-$0.14-$0.40-$0.40